Astrazeneca has accepted a proposal for cooperation from the developers of the Vaccine from the Coronavirus "Sputnik V" and will launch clinical studies of the combination of its and Russian product. For ASTRAZENECA, this is an opportunity to make the vaccine more efficiently, and for “satellite V” to confirm that the Russian vaccine is working.

The topic of release is the unmanned war of Yandex and Sberbank. Yandex has been working on an unmanned car for almost five years, Sberbank for about a year. Can he catch up with a competitor? We tell you what Russian developers have already achieved, in which they are inferior to American and Chinese, what tasks to solve and what is in the way. The full text of this story can be read here .

British company AstraZeneca, which is developing an inexpensive and mass-produced "Oxford" coronavirus vaccine, has announced the purchase of the American Alexion Pharmaceuticals, Bloomberg reported . The deal is valued at $39 billion. Under the terms of the deal, Alexion shareholders will receive $60 per share and 2.1243 ADS of AstraZeneca itself. The list price per share is $175, which means a 45% premium: Alexion shares closed at $121 on Friday.

A Brexit without a trade deal is becoming more likely, spoke both British Prime Minister Boris Johnson and European Commission President Ursula von der Leyen about this week. But for many investors, even a bad but certain outcome will be favorable, writes the Financial Times. Due to the multi-year Brexit saga, pound-denominated assets are fundamentally undervalued, according to several hedge fund managers.

After the indignant speech of Vladimir Putin that the products become “not pocket” to the population, the government took up the limitation of oil and sugar prices, and the Prosecutor General’s Office is looking for a cartel conspiracy in the market. We asked economists about what could come of it.

The American regulator FDA has approved the Pfizer and BioNTech coronavirus vaccine for emergency use. This means the launch of a mass vaccination campaign in the United States, which will only be held back by the physical presence of the vaccine and its difficult logistics.

The FDA has approved Pfizer and BioNTech's coronavirus vaccine for emergency use. This means launching a mass vaccine campaign in the US, which will only be held back by the physical presence of the vaccine and its difficult logistics.

The American FDA regulator approved the PFIZER and BIONTECH coronavirus vaccine for emergency use. This means launching a mass vaccination company in the United States, which will only be restrained by the physical presence of a vaccine and its difficult logistics.

The government wants to regulate prices and print digital money for investment growth. But get scared early This week, the government twice forced to recall the planned economy. At first, the Ministry of Economics and the Ministry of Economy got into the media, which also suggests a monetary issue to finance projects important for the state. And then the government, having listened to Vladimir Putin's indignant speech about the increase in food prices, quickly began to regulate them.